(Q47785550)

5 February 2018

title

Radiotherapy alone or combined with carbogen breathing for squamous cell carcinoma of the head and neck: a prospective, randomized trial (English)

1 reference

5 February 2018

adaptive radiation therapy

main subject

0 references

breathing

1 reference

head and neck squamous cell carcinoma

inferred from title

1 reference

William M Mendenhall

1

1 reference

5 February 2018

Christopher G Morris

2

1 reference

5 February 2018

Robert J Amdur

3

1 reference

5 February 2018

Nancy P Mendenhall

4

1 reference

5 February 2018

Dietmar W Siemann

5

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 July 2005

1 reference

5 February 2018

published in

Cancer

1 reference

5 February 2018

volume

104

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

332-337

1 reference

5 February 2018

The histological structure of some human lung cancers and the possible implications for radiotherapy

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

The tumor microenvironment: a double-edged sword.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Dose, time, and fraction size issues for late effects in head and neck cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Effects of breathing a hyperoxic hypercapnic gas mixture on blood oxygenation and vascularity of head-and-neck tumors as measured by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

ARCON: experience in 215 patients with advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21146

7 January 2021

Identifiers

DOI

10.1002/CNCR.21146

1 reference

5 February 2018

1 reference

5 February 2018